PI: Rory Johnson

​

Our mission is to develop new treatments for common diseases based on RNA therapeutics. In particular, we develop oligonucleotide drugs targeting cancer-causing long non-coding RNAs (lncRNAs), which we discover using CRISPR-Cas genome-editing and bioinformatics.

​

We are an interdisciplinary research group based at University College Dublin, and funded by Science Foundation Ireland through the 'Future Research Leaders' programme.
 

For more information go to Projects

​

​